Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.3K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.3K
Cancer Therapies02:49

Cancer Therapies

7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Skin Cancer01:30

Skin Cancer

4.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Different event-related potential responses during face processing between siblings of autistic individuals and neurotypical infants: A systematic review and meta-analysis.

Neuroscience and biobehavioral reviews·2026
Same author

A regulatory circuitry driving a noradrenergic to mesenchymal transition highlights YAP/TAZ as critical players in neuroblastoma plasticity.

Cell reports·2026
Same author

The United Kingdom National Programme of DCD heart transplantation: Timings, techniques, feasibility, and outcomes with abdominal normothermic regional perfusion.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Expanding the Spectrum of Ubiquitin-specific Proteases-Fused Neoplasms: A Clinicopathologic and Molecular Study of USP2- and USP8-Rearranged Spindle Cell Tumors.

The American journal of surgical pathology·2026
Same author

[Role of a National Multidisciplinary Tumor Board in the diagnostic and therapeutic management of patients with cancers of unknown primary (CUP)].

Bulletin du cancer·2026
Same author

Liver and peritoneal metastases of unknown primary site: French Intergroup Clinical Practice guidelines for diagnosis, treatment, and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, SFP, SFR, ACHBT, SFRO, SNFCP, AFEF, RENAPE, NET-CAPI).

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026
Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026
See all related articles

Related Experiment Video

Updated: Aug 26, 2025

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.2K

Small round cell sarcomas.

Florencia Cidre-Aranaz1,2, Sarah Watson3,4, James F Amatruda5,6

  • 1Division of Translational Paediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany. florencia.cidrearanaz@kitz-heidelberg.de.

Nature Reviews. Disease Primers
|October 6, 2022
PubMed
Summary
This summary is machine-generated.

Undifferentiated small round cell sarcomas (SRCSs) are aggressive tumors with poor prognoses. Genetic abnormalities define these SRCS entities, driving research for better detection and treatment strategies.

More Related Videos

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.2K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.1K

Related Experiment Videos

Last Updated: Aug 26, 2025

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.2K
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.2K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.1K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Undifferentiated small round cell sarcomas (SRCSs) are aggressive bone and soft tissue tumors with poor prognoses, particularly in metastatic cases.
  • These tumors primarily affect individuals in their third decade of life, showing variations in sex predilection and localization.
  • SRCSs are characterized by specific genetic abnormalities, including EWSR1-non-ETS fusions, CIC-rearrangements, BCOR alterations, and EWSR1-ETS fusions in Ewing sarcoma.

Purpose of the Study:

  • To review the current understanding of SRCS entities, focusing on their genetic underpinnings and clinical characteristics.
  • To highlight the molecular mechanisms involving oncogenic transcription factors that alter cellular gene expression and epigenomes.
  • To discuss current treatment approaches and their limitations, emphasizing the need for improved strategies.

Main Methods:

  • Review of existing literature on SRCS classification, genetic alterations, and clinical behavior.
  • Analysis of molecular mechanisms, including gene fusions and their impact on cellular function.
  • Evaluation of diagnostic markers and therapeutic strategies for SRCS management.

Main Results:

  • SRCSs are classified into distinct entities based on specific genetic alterations (EWSR1-non-ETS, CIC, BCOR, EWSR1-ETS fusions).
  • These genetic alterations lead to aberrant oncogenic transcription factors that significantly reprogram the transcriptome and epigenome.
  • Histologically, SRCSs show small round cells with variable expression of CD99 and specific markers like cyclin B3, ETV4, WT1, NKX3-1, and aggrecan.

Conclusions:

  • Understanding the molecular basis of SRCSs is crucial for improving early detection and disease monitoring.
  • Current treatment strategies, often based on Ewing sarcoma protocols, have limitations and adverse effects.
  • Emerging research and genetically engineered models offer promise for enhanced diagnostics, targeted therapies, and improved patient outcomes, including quality of life.